Cipher Pharmaceuticals Inc.
CPHRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $33,363 | $21,162 | $20,675 | $21,943 |
| % Growth | 57.7% | 2.4% | -5.8% | – |
| Cost of Goods Sold | $9,260 | $4,069 | $3,992 | $3,684 |
| Gross Profit | $24,103 | $17,093 | $16,683 | $18,259 |
| % Margin | 72.2% | 80.8% | 80.7% | 83.2% |
| R&D Expenses | $0 | $139 | $98 | $88 |
| G&A Expenses | $10,690 | $4,673 | $4,400 | $0 |
| SG&A Expenses | $12,238 | $5,425 | $5,535 | $5,112 |
| Sales & Mktg Exp. | $1,548 | $752 | $1,135 | $0 |
| Other Operating Expenses | $4,017 | $0 | $0 | $1,250 |
| Operating Expenses | $16,255 | $5,564 | $5,633 | $6,450 |
| Operating Income | $7,848 | $11,529 | $11,085 | $11,821 |
| % Margin | 23.5% | 54.5% | 53.6% | 53.9% |
| Other Income/Exp. Net | -$4,893 | $1,152 | -$560 | -$2,000 |
| Pre-Tax Income | $2,955 | $12,681 | $11,479 | $11,059 |
| Tax Expense | -$8,590 | -$7,702 | -$15,157 | $3,301 |
| Net Income | $11,545 | $20,383 | $26,636 | $7,758 |
| % Margin | 34.6% | 96.3% | 128.8% | 35.4% |
| EPS | 0.47 | 0.82 | 1.01 | 0.29 |
| % Growth | -42.7% | -18.8% | 248.3% | – |
| EPS Diluted | 0.46 | 0.8 | 0.99 | 0.29 |
| Weighted Avg Shares Out | 24,721 | 25,005 | 25,376 | 26,598 |
| Weighted Avg Shares Out Dil | 25,222 | 25,422 | 25,799 | 26,830 |
| Supplemental Information | – | – | – | – |
| Interest Income | $330 | $1,870 | $464 | $12 |
| Interest Expense | $0 | $0 | $0 | $92 |
| Depreciation & Amortization | $4,017 | $1,227 | $950 | $695 |
| EBITDA | $11,865 | $11,529 | $11,951 | $13,659 |
| % Margin | 35.6% | 54.5% | 57.8% | 62.2% |